SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-148602
Filing Date
2024-05-29
Accepted
2024-05-29 07:06:00
Documents
14
Period of Report
2024-05-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d796778d8k.htm   iXBRL 8-K 30401
2 EX-10.1 d796778dex101.htm EX-10.1 100940
  Complete submission text file 0001193125-24-148602.txt   281905

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA blue-20240528.xsd EX-101.SCH 2863
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE blue-20240528_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blue-20240528_pre.xml EX-101.PRE 10821
17 EXTRACTED XBRL INSTANCE DOCUMENT d796778d8k_htm.xml XML 3503
Mailing Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145
Business Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145 339-499-9300
bluebird bio, Inc. (Filer) CIK: 0001293971 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35966 | Film No.: 24993993
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)